132 related articles for article (PubMed ID: 18628356)
41. BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.
Goutas N; Vlachodimitropoulos D; Bouka M; Lazaris AC; Nasioulas G; Gazouli M
Anticancer Res; 2008; 28(1A):305-8. PubMed ID: 18383861
[TBL] [Abstract][Full Text] [Related]
42. Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.
Howell GM; Carty SE; Armstrong MJ; Lebeau SO; Hodak SP; Coyne C; Stang MT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
Ann Surg Oncol; 2011 Dec; 18(13):3566-71. PubMed ID: 21594703
[TBL] [Abstract][Full Text] [Related]
43. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.
Cañadas-Garre M; Becerra-Massare P; López de la Torre-Casares M; Villar-del Moral J; Céspedes-Mas S; Vílchez-Joya R; Muros-de Fuentes T; García-Calvente C; Piédrola-Maroto G; López-Nevot MA; Montes-Ramírez R; Llamas-Elvira JM
Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197
[TBL] [Abstract][Full Text] [Related]
44. BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion?
Cameselle-Teijeiro J; Abdulkader I; Pérez-Becerra R; Vázquez-Boquete A; Alberte-Lista L; Ruiz-Ponte C; Forteza J; Sobrinho-Simões M
Hum Pathol; 2009 Jul; 40(7):1029-35. PubMed ID: 19269016
[TBL] [Abstract][Full Text] [Related]
45. [Frequency of RET/PTC rearrangement and somatic BRAF mutation in papillary thyroid cancer].
Rumiantsev PO; Zaletaev DV; Vasil'ev EV; Saenko VA; Il'in AA; Rumiantseva UV; Abrosimov AIu; Medvedev VS
Vopr Onkol; 2006; 52(2):145-9. PubMed ID: 17195637
[TBL] [Abstract][Full Text] [Related]
46. Significance of p53-binding protein 1 (53BP1) expression in thyroid papillary microcarcinoma: association with BRAFV600E mutation status.
Mussazhanova Z; Matsuda K; Naruke Y; Mitsutake N; Stanojevic B; Rougounovitch T; Saenko V; Suzuki K; Nishihara E; Hirokawa M; Ito M; Nakashima M
Histopathology; 2013 Nov; 63(5):726-34. PubMed ID: 24004175
[TBL] [Abstract][Full Text] [Related]
47. Radiation induced thyroid cancer: fundamental and applied aspects.
Tronko M; Bogdanova T; Voskoboynyk L; Zurnadzhy L; Shpak V; Gulak L
Exp Oncol; 2010 Sep; 32(3):200-4. PubMed ID: 21403618
[TBL] [Abstract][Full Text] [Related]
48. High prevalence of B-RAF mutation in papillary carcinoma of the thyroid in north-east Italy.
Girlando S; Cuorvo LV; Bonzanini M; Morelli L; Amadori P; Dalla Palma P; Barbareschi M
Int J Surg Pathol; 2010 Jun; 18(3):173-6. PubMed ID: 20460314
[TBL] [Abstract][Full Text] [Related]
49. BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases.
Fakhruddin N; Jabbour M; Novy M; Tamim H; Bahmad H; Farhat F; Zaatari G; Aridi T; Kriegshauser G; Oberkanins C; Mahfouz R
Sci Rep; 2017 Jul; 7(1):4666. PubMed ID: 28680105
[TBL] [Abstract][Full Text] [Related]
50. Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma.
Trovisco V; Couto JP; Cameselle-Teijeiro J; de Castro IV; Fonseca E; Soares P; Sobrinho-Simões M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):683-5. PubMed ID: 18363883
[No Abstract] [Full Text] [Related]
51. Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas.
Wang W; Wang H; Teng X; Wang H; Mao C; Teng R; Zhao W; Cao J; Fahey TJ; Teng L
Hum Pathol; 2010 Sep; 41(9):1299-309. PubMed ID: 20471663
[TBL] [Abstract][Full Text] [Related]
52. Loss of Heterozygosity (LOH) at 17p13 and 22q13 are Shared by Breast and Thyroid Carcinomas for Metastasis.
Lin X; Finkelstein SD; Silverman JF
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):e16-e19. PubMed ID: 30688674
[TBL] [Abstract][Full Text] [Related]
53. Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma.
Jovanovic L; Delahunt B; McIver B; Eberhardt NL; Bhattacharya A; Lea R; Grebe SK
Pathology; 2010; 42(6):524-33. PubMed ID: 20854070
[TBL] [Abstract][Full Text] [Related]
54. Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis.
Oler G; Ebina KN; Michaluart P; Kimura ET; Cerutti J
Clin Endocrinol (Oxf); 2005 Apr; 62(4):509-11. PubMed ID: 15807885
[No Abstract] [Full Text] [Related]
55. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone.
Jovanovic L; Delahunt B; McIver B; Eberhardt NL; Grebe SK
J Pathol; 2008 Jun; 215(2):145-54. PubMed ID: 18393366
[TBL] [Abstract][Full Text] [Related]
56. Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis.
Jeon MJ; Chun SM; Lee JY; Choi KW; Kim D; Kim TY; Jang SJ; Kim WB; Shong YK; Song DE; Kim WG
Endocrine; 2019 Apr; 64(1):130-138. PubMed ID: 30645724
[TBL] [Abstract][Full Text] [Related]
57. Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.
Oler G; Camacho CP; Hojaij FC; Michaluart P; Riggins GJ; Cerutti JM
Clin Cancer Res; 2008 Aug; 14(15):4735-42. PubMed ID: 18676742
[TBL] [Abstract][Full Text] [Related]
58. Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines.
Finn S; Smyth P; O'Regan E; Cahill S; Toner M; Timon C; Flavin R; O'Leary J; Sheils O
Arch Pathol Lab Med; 2007 Jan; 131(1):65-73. PubMed ID: 17227125
[TBL] [Abstract][Full Text] [Related]
59. Thyroid carcinoma with papillary and squamous features: report of a case with histogenetic considerations.
Rausch T; Benhattar J; Sutter M; Andrejevic-Blant S
Pathol Res Pract; 2010 Apr; 206(4):263-9. PubMed ID: 19493635
[TBL] [Abstract][Full Text] [Related]
60. [Research progress on the relationship between the Raf murine sarcoma viral oncogene homolog B gene mutation and lymph node metastasis of papillary thyroid carcinoma].
Wang Y; Wen Y; Lin S; Wen D; Xie J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2021 Feb; 38(1):191-195. PubMed ID: 33899445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
